marijuana stocks

Agritek Holdings, Inc. (AGTK)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
Total Revenue 2   4   20   8  
Cost of Revenue 19 (1) 21 19
Gross Profit (17) 5   (2) (11)
Operating Expenses
Research Development
Selling General and Administrative 444 271 164 204
Non Recurring 17 27
Others
Total Operating Expenses
Operating Income or Loss (478) (266) (165) (241)
Income from Continuing Operations
Total Other Income/Expenses Net (37) 95 41 (341)
Earnings Before Interest And Taxes (515) (171) (124) (515)
Interest Expense 29 225 111 124
Income Before Tax (544) (396) (236) (639)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (544) (396) (236) (572)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (544) (396) (236) (639)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (544) (396) (236) (639)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Plandai Biotechnology Inc. (PLPL) Phytofare® Green Tea Catechins as a Phytogenic Substance in Poultry Diets

Plandai Biotechnology’s Phytofare® Green Tea Catechins as a Phytogenic Substance in Poultry…

Jushi Holdings Inc. (JUSHF) Reports Third Quarter 2021 Financial Results

Jushi Holdings Inc. Reports Third Quarter 2021 Financial Results Jushi Holdings Inc.…

$FULL Announces Second Quarter Fiscal 2015 Earnings

Full Circle Capital Corporation Announces Second Quarter Fiscal 2015 Earnings – Closed…

GT Biopharma Inc. (GTBP) Starts FDA Phase 1 Clinical Trial for Myasthenia Gravis Autoimmune Muscular Disease

GT Biopharma, Inc. Starts FDA Phase 1 Clinical Trial for Myasthenia Gravis…